Please assess the completion status of the following clinical trial:

Trial Title: Probiotics for Reduction of Infections With Clostridium Difficile in Critically Ill Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Anticipated need for intensive care 3 days or longer~* Patients condition allowing enteral nutrition to be started within 24 h from ICU admission~* Antibiotics on-going or planned~Exclusion Criteria:~* Known positive test for Clostridium difficile within the last week~* Known ulcers in the mouth, oropharynx, esophagus and stomach~* Known immune deficiencies~* Enteral nutrition contra indicated~* Pancreatitis as admission diagnosis at the hospital or at the ICU~* ICU admission earlier during this period of illness Patient being moribund

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Probiotics (Type: EXPERIMENTAL): Patients will be given a mixture of maltodextrin ( a starch product often used i alimentary products) and two strains of probiotic bacteria ( L. plantarum 299 and L. plantarum 299v ) dissolved in water through a nasogastric tube. Patients randomized 1:1 between groups
- Control (Type: PLACEBO_COMPARATOR): Patients will be given only the dissolved maltodextrin in water through the nasogastric tube. Patients randomized 1:1 between groups

Based on this trial design, predict the completion outcome and termination type (if applicable).